期刊文献+

蛋白质摄入水平对腹膜透析患者早期营养状况的影响 被引量:9

Influence of protein intake levels on early nutritional status in peritoneal dialysis patients
原文传递
导出
摘要 目的观察每日蛋白质摄入(DPI)分别为0.8≤DPI≤1.0g·kg^-1·d^-1和1.0〈DPI≤1.2g·kg^-1·d^-1对新进入腹膜透析患者的营养状况的影响。方法选取2004年6月至2005年6个月期间进入腹膜透析且透析后1个月DPI水平在0.8≤DPI≤1.2g·kg^-1·d^-1范围的腹膜透析患者进入研究。分别于透析后1、3、6个月分别评估患者营养状况。血生化测定仪检测血红蛋白(Hh)、血白蛋白(Alb)、尿素氮(BUN)和血肌酐(Scr)水平。人体测量法测量上臂围(AC)、三头肌皮褶厚度(TSF)和上臂肌围(AMC)。肌酐动力学方法测定瘦体质量。同时监测影响营养状况的一些重要因素并进行评价,包括DPI和每日能量摄入(DEI)水平、透析充分性[总的和残肾尿素清除指数(tKt/V和rKt/V);总的和残肾的标准化肌酐清除率,(tCcr和rCcr)1、代谢性酸中毒(血CO2CP)、炎性反应状态[血C反应蛋白(CRP)]、容量指标[生物电阻抗法测定并计算细胞外液/总体水(ECW/TBW);身高标化的细胞外液(nECW)]。结果82例腹透患者进入本研究,其中39例为0.8≤DPI≤1.0g·kg^-1·d^-1,DEI(108.24±17.99)kJ·kg^-1·d^-1;43例为1.0〈DPI≤1.2g·kg^-1·d^-1,DEI(126.82±19.92)kJ·kg^-1·d^-1。两组患者基础的DPI和DEI水平,3个月时DPI,6个月时DPI和DEI值差异有统计学意义(P〈0.01或0.05)。透析后半年内两组平均tKt/V和rKt/V、tCer和rCcr、CRP、CO2CP、ECW/TBW、nECW差异均无统计学意义(P〉0.05)。两组患者透析半年内均保持营养状况稳定,分别于1、3及6个月时比较各项营养指标,两组患者血Alb、BUN、Scr、Hb、AC、AMC、TSF和LBM水平差异均无统计学意义(P〉0.05)。结论新入的腹透患者不论其0.8≤DPI≤1.0g·kg^-1·d^-1,或1.0〈DPI≤1.2g·kg^-1·d^-1,均可保持透析早期的营养状况稳定,且不同DPI水平的患者透析半年内各项营养指标差异均无统计学意义。 Objective To observe the influence of daily protein intake (DPI) (0.8 ≤ DPI≤1.0 g·kg^-1·d^-1 or 1.0〈DPI≤ 1.2 g·kg^-1·d^-1) on early nutritional status in peritoneal dialysis (PD) patients. Methods New PD patients from June 2004 to June 2005 with DPI level between 0.8 g·kg^-1·d^-1 and 1.2 g·kg^-1·d^-1 on the first month of peritoneal dialysis were enrolled in the study. Nutritional status and nutrition-related factors were assessed on the month 1,3 and 6 after PD. Hemoglobin(Hb), serum albumin(Alb), urea nitrogen (BUN) and serum creatinine (Scr), direct anthropometry [arm circumference (AC), triceps skin-fold thickness (TSF), arm muscle ciucumference (AMC)] and lean body mass (LBM) were examined as nutritional indices. Nutritionrelated factors including DPI and daily energy intake (DEI), dialysis adequacy (total and renal Kt/V, total and renal Ccr), metabolic acidosis (CO2CP), inflammation (serum CRP), volume status [extracellular water(ECW), intracellular water(ICW), total body water(TBW), calculated ECW/TBW and normalized ECW] were analyzed respectively. Results Eighty-two PD patients were included in the study. Thirty-nine patients were 0.8 g·kg^-1·d^-1 ≤DPI ≤1.0 g·kg^-1·d^-1 and the other 43 patients were 1.0 g·kg^-1·d^-1≤DPI≤1.2 g·kg^-1·d^-1 There were significant differences of baseline DPI and DEI levels, DPI on the 3rd month, DPI and DEI on the 6th month between two groups (P〈0.05). The average tKt/V, rKt/V, tCcr, rCcr, CRP, CO2CP, ECW/TBW and nECW were not significantly different between two groups during the six months of PD (P〉0.05). All the patients maintained good nutritional status. Serum levels of Alb, BUN, Scr, Hb, AC, AMC, TSF and LBM in patients on the 1st, 3rd and 6th month of PD were not significantly different between two groups(P〉0.05). Conclusions New PD patients can maintain good nutrition on the early stage of dialysis whether their DPI levels are 0.8 g·kg^-1·d^-1≤DPI≤l.0 g·kg^-1·d^-1 or 1.0 g·kg^-1·d^-1〈DPI ≤ 1.2 g ·kg^-1·d^-1. All nutritional indices are not significantly different between two groups in the first six months.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2008年第2期86-90,共5页 Chinese Journal of Nephrology
关键词 腹膜透析 营养 蛋白质 Peritoneal dialysis Nutrition Protein
  • 相关文献

参考文献19

  • 1K/DOQI, National Kidney Foundation. Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis, 2000,35(6 Suppl 2):S1-S140.
  • 2Kopple JD, National Kidney Foundation K/DOQI Work Group. The National Kidney Foundation K/DOQI clinical practice guidelines for dietary protein intake for chronic dialysis patients. Am J Kidney Dis, 2001,38 (4 Suppl 1): S68-S73.
  • 3Tian XK, Wang T. A low-protein diet does not necessarily lead to malnutrition in peritoneal dialysis patients. J Ren Nutr, 2005,15:298-303.
  • 4Wong KC, Xiong DW, Kerr PG, et al. Kt/V in CAPD by different estimations of V. Kidney Int, 1995,48:563-569.
  • 5Uribarri J. Doqi guidelines for nutrition in long-term peritoneal dialysis patients: a dissenting view. Am J Kidney Dis, 2001,37:1313-1318.
  • 6Nakao T, Matsumoto H, Okada T, et al. Nutritional management of dialysis patients: balancing among nutrient intake, dialysis dose, and nutritional status. Am J Kidney Dis, 2003,41(3 Suppl 1):S133-S136.
  • 7Sutton D, Talbot ST, Stevens JM. Is there a relationship between diet and nutrition status in continuous ambulatory peritoneal dialysis patients? Petit Dial Int, 2001,21 Suppl 3: S168-S173.
  • 8Giordano C, De Santo NG, Pluvio M, et al. Protein requirements of patients on CAPD: a study of nitrogen balance. Int J Artif Organs, 1980,3:11-14.
  • 9Blumenkrantz MJ, Kopple JD, Moran JK, et al. Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int, 1982,21:849-861.
  • 10Food and Nutrition Board, National Research Council, National Academy of Sciences: Recommended dietary allowances. 10th ed. Washington DC: National Academy Press, 1959:52-57.

二级参考文献17

  • 1Young GA, Kopple JD, Lindholm B, et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis,1991,17:462-471.
  • 2Bargman JM, Bick J, Cartier P, et al. Guidelines for adequacy and nutrition in peritoneal dialysis. Canadian Society of Nephrology. J Am Soc Nephrol,1999 ,10 Suppl 13:S311-321.
  • 3Jones CH, Newstead CG. The ratio of extracellular fluid to total body water and technique survival in peritoneal dialysis patients. Petit Dial Int,2004,24:353-358.
  • 4Locatelli F, Mareelli D, Conte F, et al. Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. J Am Soc Nephrol,2001,12 :2411-2417.
  • 5Davies SJ, Phillips L, Griffiths AM, et al. What really happens to people on long-term peritoneal dialysis? Kidney Int, 1998,54: 2207-2217.
  • 6Wang T, Lindholm B. Beyond CANUSA, DOQI, ADEMEX: what's next? Adequacy of Peritoneal Dialysis in Mexico. CanadaUSA. Dialysis Outcomes Quality Initiative. Perit Dial Int, 2002, 22:555-562.
  • 7Lim VS, Flanigan MJ. Protein intake in patients with renal failure: comments on the current NKF-DOQI guidelines for nutrition in chronic renal failure. Semin Dial,2001,14:150-152.
  • 8Bergstrom J, Lindholm B. Malnutrition, cardiac disease, and mortality. Perit Dial Int, 1999,19 Suppl 2 : S309-314.
  • 9Tang W, Cheng LT, Wang T. Diabetic patients can do as well on peritoneal dialysis as nondiabetic patients. Blood Purif, 2005,23: 330-337.
  • 10Burrowes JD, Cockram DB, Dwyer JT, et al. Cross-sectional relationship between dietary protein and energy intake, nutritional status, functional status, and comorbidity in older versus younger hemodialysis patients. J Ben Nutr, 2002,12 : 87 -95.

共引文献120

同被引文献114

  • 1向晶,曾鹂,马志芳.2种无肝素操作方法在连续性肾脏替代治疗中的比较[J].中国血液净化,2012,11(8):455-456. 被引量:21
  • 2于玲,李寒,王世相.维持性血液透析患者抑郁障碍调查及相关因素分析[J].中国血液净化,2012,11(1):22-24. 被引量:21
  • 3张勇,孟熙,和卫梅,曹礼应,余月明.不同血管通路对血液透析患者透析充分性及并发症的影响[J].中国血液净化,2012,11(5):256-258. 被引量:27
  • 4钱家麒.腹膜透析中需要关注的几个问题[J].中华肾脏病杂志,2005,21(5):240-241. 被引量:11
  • 5Roberts MA. Dialysis patients without known cardiovascular disease have high cardiovascular mortality: analysis of the Australia and New Zealand dialysis and transplant (ANZDATA) registry. Program and abstracts of the American Society of Nephrology 2006 Annual Meeting, San Diego, California. Washington DC: American Society of Nephrology, 2006.
  • 6Sommerer C, Beimler J, Schwenger V, et al. Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest, 2007,37:350-356.
  • 7Wanner C, Krane V, Marz W, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med, 2005,353:238-248.
  • 8Zannad F, Kessler M, Lehert P, et al. Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int, 2006,70:1318-1324.
  • 9Takahashi A, Takase H, Toriyama T, et al. Candesartan, an angiotensin Ⅱ type- 1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis-a randomized study. Nephrol Dial Transplant, 2006,21:2507- 2512.
  • 10Cice G, Ferrara L, D' Andrea A, et al. Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial. J Am Coll Cardiol, 2003,41:1438-1444.

引证文献9

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部